Expression decreases with disease progression. Genetic analyses showed that when EPHB6 overexpression accompanies mutations in the APC gene, the tumor acquires significant advantages in cell proliferation, invasion, and metastasis. On the other hand, reduced levels of EphB6 were associated with advanced disease stages and therefore correlated with a poor prognosis. The gene discussed is EPHB6; the disease is neoplasm.